Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | Chief Financial Officer | $2.78M | -$195K | -6.56% | Mar 6, 2024 |
AVTX | Avalo Therapeutics, Inc. | Director | Mar 31, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|